Response to: ‘The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis’ by González-Gay et al

In their comments about our systematic review on cardiovascular (CV) comorbidities in patients with psoriatic arthritis,1 Gonzalez-Gay et al 2 point out that in their studies, in contrast to our table 4, they did demonstrate a correlation between inflammatory parameters and flow-mediated dilatation …